EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,585,113 | +1208.4% | 4,487 | -80.1% | 0.43% | +1097.2% |
| Q1 2022 | $274,000 | +4.6% | 22,552 | +5.3% | 0.04% | -7.7% |
| Q4 2021 | $262,000 | -31.1% | 21,427 | -41.2% | 0.04% | +44.4% |
| Q3 2021 | $380,000 | -87.1% | 36,427 | -88.9% | 0.03% | -88.7% |
| Q2 2021 | $2,955,000 | -11.4% | 328,635 | 0.0% | 0.24% | +113.4% |
| Q1 2021 | $3,337,000 | +2704.2% | 328,635 | +1735.9% | 0.11% | +2140.0% |
| Q4 2020 | $119,000 | – | 17,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |